An Epstein-Barr virus-associated pulmonary lymphoproliferative disorder as complication of immunosuppression

Neth J Med. 2000 Oct;57(4):165-8. doi: 10.1016/s0300-2977(00)00065-6.

Abstract

Inherited or acquired immunodeficiencies as well as autoimmune diseases treated with cytotoxic drugs are associated with an increased incidence of lymphoma. Non-Hodgkin's lymphomas that occur in the context of drug-induced immunosuppression, acquired or congenital immunodeficiency, are frequently associated with Epstein-Barr virus infection. This report describes the occurrence of an Epstein-Barr virus associated pulmonary B cell lymphoma in a patient with longstanding rheumatoid arthritis treated with methotrexate.

Publication types

  • Case Reports

MeSH terms

  • Arthritis, Rheumatoid / drug therapy*
  • Biopsy, Needle
  • Epstein-Barr Virus Infections / complications*
  • Humans
  • Immunocompromised Host*
  • Immunosuppressive Agents / adverse effects*
  • Lung Neoplasms / chemically induced*
  • Lung Neoplasms / diagnosis
  • Lung Neoplasms / immunology
  • Lung Neoplasms / virology*
  • Lymphoma, B-Cell / chemically induced*
  • Lymphoma, B-Cell / diagnosis
  • Lymphoma, B-Cell / immunology
  • Lymphoma, B-Cell / virology*
  • Male
  • Methotrexate / adverse effects*
  • Middle Aged
  • Risk Factors
  • Tomography, X-Ray Computed

Substances

  • Immunosuppressive Agents
  • Methotrexate